2019 sees the return of our popular 8th Annual Cell Culture & Bioprocessing, 6th Annual Stem Cell & Regenerative Medicine and 5th Annual Cell & Gene Therapy Congresses, designed to provide updates on the novel technologies and therapeutic strategies propelling this marketplace forward: from tools to improve effectiveness in cell line development to clinical case studies in cell and gene therapies. In line with current European trends and concerns, the congress also features focussed sessions on effective methods for bioprocessing and manufacturing, including of CAR-T and stem cell therapies, as well as a brand-new focus session on Cell Banking.
We are pleased to announce our inaugural Cell Culture & Bioprocessing USA Congress, taking place in Boston next year. Addressing both early and late stage cell line development as well as process development updates, the event is a must to attend for anyone wanting to acquire a deeper understanding of 3D cell cultures, automation in cell line development and the applications of ‘omics technologies in cell line development. Through the co-located Cell & Gene Therapy USA Congress, delegates will have the chance to learn more about the latest commercialisation and market access strategies for cellular & gene therapies as well as recent updates from clinical trials.
Key Topic Areas Covered:
Follow us on